Cover Image

Infant deaths in the EudraVigilance database

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	David N. Juurlink, Jonathan S. Zipursky
Format:	Artículo Open Access
Published:	Wiley 2026
Subjects:	British Journal of Clinical Pharmacology
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Acetazolamide‐induced pulmonary oedema: A disproportionality analysis from the EudraVigilance database
by: Montserrat García, et al.
Published: (2024)

EudraVigilance insights: Suspected adverse drug reactions in infants through breastfeeding
by: Ida M. Heerfordt, et al.
Published: (2025)

Severe myelosuppression and alopecia after thiopurine initiation in a patient with NUDT15 deficiency
by: Annie Siyu Wu, et al.
Published: (2025)

Opioid‐related deaths and their counterpart by occurrence era, age group and coimplicated drugs: Scotland vs. England and Wales
by: Sheila Macdonald Bird
Published: (2024)

The NOS1AP gene rs10494366 common genetic variant does not modify the risk of sudden cardiac death in users of digoxin
by: Negin Soroush, et al.
Published: (2024)

Co‐prescription of low‐dose methotrexate and trimethoprim‐sulfamethoxazole and the 30‐day risk of death among older adults: A cohort study
by: Hasti Sadeghi, et al.
Published: (2024)

Thirst and drugs: A study in the World Health Organization's pharmacovigilance database
by: Jean‐Louis Montastruc
Published: (2024)

Analysis of interstitial lung disease in pharmacovigilance databases: Coding challenges and interpretation biases—An update
by: Romane Freppel, et al.
Published: (2026)

Pharmacovigilance of obeticholic acid: An analysis of the Food and Drug Administration Adverse Event Reporting System database
by: Qining He, et al.
Published: (2025)

The prevalence of polypharmacy in older Europeans: A multi‐national database study of general practitioner prescribing
by: Marion Bennie, et al.
Published: (2024)

Risk of major congenital anomalies and beta‐blockers: A comparative study from the EFEMERIS database
by: Laurane Delteil, et al.
Published: (2025)

Drug‐induced liver injury associated with pretomanid, bedaquiline, and linezolid: Insights from FAERS database analysis
by: Qingfeng He, et al.
Published: (2024)

Economic evaluations of therapeutic drug monitoring interventions in acute hospital‐based settings: A systematic review
by: Jane E. Carland, et al.
Published: (2024)

Exploring Definity‐related adverse reaction: A real‐world pharmacovigilance study via FAERS database analysis
by: Wenrong Lin, et al.
Published: (2025)

Disproportionality analysis of cardiac adverse events associated with lenvatinib using the Japanese Adverse Drug Event Report database
by: Yuko Kanbayashi, et al.
Published: (2024)

A study on adverse events of botulinum toxin type A in real‐world applications: A FAERS database analysis
by: Weizhen He, et al.
Published: (2025)

Variability in the prevalence of inappropriate medication use among older adults: A review highlighting the importance of screening methods and database types
by: Romain Léguillon, et al.
Published: (2024)

Comprehensive safety assessment of ribociclib: A real‐world analysis using the FDA Adverse Event Reporting System (FAERS) database
by: Lan Luo, et al.
Published: (2025)

Medication adherence to inflammatory bowel disease medications in Aotearoa New Zealand and correlation with health outcomes: A nationwide database analysis
by: Obreniokibo Ibifubara Amiesimaka, et al.
Published: (2024)

Association between ramelteon and 30‐day mortality in ICU patients with COVID‐19: A retrospective analysis of the MIMIC‐IV database
by: Yu Tian, et al.
Published: (2025)

Letter to the editor—Response to the article “Drug‐induced liver injury associated with pretomanid, bedaquiline, and linezolid: Insights from FAERS database analysis”
by: Jaya Ranjalkar, et al.
Published: (2025)

Cardiovascular events of Bruton's tyrosine kinase inhibitors: A real‐world study based on the United States Food and Drug Administration Adverse Event Reporting System database
by: Zeng‐Xiang Zhao, et al.
Published: (2024)

A tale of 2 digital hospitals: A qualitative study of antimicrobial stewardship teams
by: Bethany A. Van Dort, et al.
Published: (2024)

Effects of age, sex, daily dose, comorbidity and co‐medication on venlafaxine‐associated cardiovascular adverse events: A pharmacovigilance analysis of the FDA Adverse Event Reporting System database
by: Zhanzhang Wang, et al.
Published: (2024)

From cradle to cane—(Dis)similarities between paediatric and geriatric clinical pharmacology: A commentary arising from the 2024 International Union of Basic and Clinical Pharmacology (IUPHAR) World Smart Medication Day
by: Karel Allegaert, et al.
Published: (2025)

Equity and quality use of medicines in people who present to the Psychiatric Alcohol and Non‐Prescription Drug Assessment Unit
by: Jana Stojanova, et al.
Published: (2025)

Estimation of adherence to urate‐lowering therapy in people living with gout using Australia's Pharmaceutical Benefits Scheme and patient‐reported dosing
by: Marcel Schulz, et al.
Published: (2024)

The clinical pharmacology and therapeutics course for graduating medical students at Dartmouth: Preparation for internship and residency
by: David W. Nierenberg, et al.
Published: (2024)

What can pharmacokinetic modelling do for you? Rational design and interpretation of clinical studies
by: Francis Williams Ojara, et al.
Published: (2024)

Frailty in clinical drug trials: Frailty assessments, subgroup analyses and outcomes
by: Tu N. Nguyen, et al.
Published: (2024)

Pharmacokinetic‐pharmacodynamic modelling of risankizumab using chronic plaque psoriasis real‐world data
by: Charlotte M. Thomas, et al.
Published: (2026)

External evaluation of intravenous vancomycin population pharmacokinetic models in adults receiving high‐flux intermittent haemodialysis
by: Cheng Ji, et al.
Published: (2024)

Evaluating the evidence for genotype‐informed Bayesian dosing of tacrolimus in children undergoing solid organ transplantation: A systematic literature review
by: Dhrita Khatri, et al.
Published: (2024)

Feasibility and evaluation of high‐fidelity simulation education for acute clinical toxicology
by: David J. Brinkman, et al.
Published: (2024)

Comparing regulatory guidance on risk minimization/mitigation and the Reporting recommendation Intended for pharmaceutical Risk Minimization Evaluation Studies checklist
by: Sonia Guleria, et al.
Published: (2024)

Global and regional knowledge of antibiotic use and resistance among healthcare students: A systematic review and meta‐analysis
by: Asa Auta, et al.
Published: (2026)

Oseltamivir drug‐disease modelling in infants with influenza virus infection
by: Kun Wang, et al.
Published: (2026)

Exploring new avenues: Psychedelic‐assisted therapy for young people
by: Ioanna Artemis Vamvakopoulou, et al.
Published: (2026)

Physiologically based pharmacokinetic model combined with a clinical lactation study to determine doravirine concentrations in human breastmilk
by: Lena van der Wekken‐Pas, et al.
Published: (2025)

Medication review interventions for adults living with advanced chronic kidney disease: A scoping review
by: Cathy Margaret Pogson, et al.
Published: (2024)